Can This Common Medication Help Reduce The Risk Of Long COVID?


A recent study suggests that the treatment may help some high-risk people following an infection. By Casey Clark Aug 29, 2023 It seems like every time you turn on the news or open your phone, new information about COVID-19 pops up. Most of this information is pertinent to the latest variant EG.5, also called “Eris,” but recently, other more […]

SARS-CoV-2 and the risk of Parkinson’s disease: facts and fantasy


Marcelo Merello, Kailash P Bhatia, Jose A Obeso Published: November 27, 2020 DOI: https://doi.org/10.1016/S1474-4422(20)30442-7 Lancet Neurology VOLUME 20, ISSUE 2, P94-95, FEBRUARY 2021 During the pandemic it has become clear that severe acure respiratory syndrome coronavirus (SARS-CoV-2) causes not just respiratory disease, but can affect multiple organs and tissues. Of note is the involvement of the CNS […]

Clinical characteristics and outcome of COVID-19 patients with Parkinson’s disease: a hospital-based case–control study in Shanghai, China


Front. Aging Neurosci., 05 May 2023 Sec. Parkinson’s Disease and Aging-related Movement DisordersVolume 15 – 2023 | https://doi.org/10.3389/fnagi.2023.1138418 Li Wu1† Jun Shen1† Yuhan Jiang1 Xiaolei Shen1 Ping Wang1 Xin Nie2 Wenyan Kang3,4* Jianren Liu1* Wei Chen1* Background: Clinical manifestations of Parkinson’s disease (PD) after Corona Virus Disease 2019 (COVID-19) infection are poorly investigated. Objective: We aimed to explore the clinical features and outcomes of hospitalized PD […]

Early-stage trial for Parkinson’s disease therapy shows signs of promise


Small trial of Bemdaneprocel, which aims to replace dopamine-producing neurons, raises hope for treatment. Hannah Devlin Science correspondent 28 Aug 2023 03.00 EDT Scientists have reported early success in a trial of an experimental cell therapy for Parkinson’s disease, raising hope for patients. Bemdaneprocel therapy is at an early stage, and the year-long trial involved just […]

COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection


Salvatore Iacono1† Giuseppe Schirò1† Chiara Davì1 Sergio Mastrilli2 Michelle Abbott3 Fabrizio Guajana1 Valentina Arnao4 Paolo Aridon1 Paolo Ragonese1 Cesare Gagliardo1 Claudia Colomba3 Nicola Scichilone5 Marco D’Amelio1* Front. Neurol., 18 May 2023 Sec. Movement Disorders Volume 14 – 2023 | https://doi.org/10.3389/fneur.2023.1172416 SARS-CoV-2 infection leading to Coronavirus disease 19 (COVID-19) rapidly became a worldwide health emergency due to its elevated infecting capacity, morbidity, and mortality. Parkinson’s disease (PD) is the […]

Covid to blame for just 1% of weekly deaths from all causes across the US, CDC data shows


By ALEXA LARDIERI U.S. DEPUTY HEALTH EDITOR DAILYMAIL.COM 29 August 2023 Covid was to blame for just 1 percent of weekly deaths from all causes across the US in the most recent week, CDC data shows. The Centers for Disease Control and Prevention (CDC) Covid dashboard shows 324 Covid deaths were registered in the week ending […]

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside


npj Parkinson’s Disease volume 6, Article number: 18 (2020) Cite this article Abstract This Viewpoint discusses insights from basic science and clinical perspectives on coronavirus disease 2019 (COVID-19)/severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection in the brain, with a particular focus on Parkinson’s disease. Major points include that neuropathology studies have not answered the central issue of whether the virus enters central […]

Large study provides scientists with deeper insight into long COVID symptoms


May 25, 2023, 11:00 AM EDT NHLBI NEWS News Release NIH-funded research effort identifies most common symptoms, potential subgroups, and initial symptom-based scoring system – with aim of improving future diagnostics and treatment Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the […]

Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)


Jim M Wild1, Joanna C Porter2,3,4, Philip L Molyneaux5,6, Peter M George5,6, http://orcid.org/0000-0002-1340-2688Iain Stewart5, Richard James Allen7, Raminder Aul8, http://orcid.org/0000-0001-5258-793XJohn Kenneth Baillie9, Shaney L Barratt10, Paul Beirne11, Stephen M Bianchi12, John F Blaikley13,14, Jonathan Brooke15,16,17, http://orcid.org/0000-0003-3325-6996Nazia Chaudhuri14,18, Guilhem Collier1, http://orcid.org/0000-0002-7695-325XEmma K Denneny2,3,4, Annemarie Docherty19, http://orcid.org/0000-0002-8250-6464Laura Fabbri5, Michael A Gibbons20,21, Fergus V Gleeson22, Bibek Gooptu23,24, Ian P Hall16,17, Neil A Hanley14,25, Melissa Heightman3, Toby E Hillman3, http://orcid.org/0000-0002-9837-2763Simon R Johnson16,17, Mark G Jones26,27, http://orcid.org/0000-0002-0796-5724Fasihul Khan16,17, Rod Lawson12, Puja Mehta2,28, Jane A Mitchell5, http://orcid.org/0000-0002-9957-0681Manuela Platé2,29, Krisnah Poinasamy30, Jennifer K Quint5, Pilar […]

Despite Recovering from COVID-19, Shortness of Breath Persists


February 21, 2022 Jane E. Dee Advanced testing of the heart and lungs may reveal why some people who have recovered from COVID-19 still have shortness of breath. This testing is highly specialized and available only at a few sites nationwide, including at Yale. Many patients continue to have ongoing symptoms well after their initial […]